Why Is Bitcoin CRASHING?! | Jordi Visser

— Bitcoin's 50% decline from all-time highs reflects a market rotation away from hardware (AI chips/infrastructure) toward software applications, not a fundamental breakdown in the asset's value thesis.

— The four-year halving cycle is less relevant now; Bitcoin and stocks are decoupling for the first time, suggesting crypto may thrive independently of traditional markets.

— AI agents will drive long-term Bitcoin adoption because agents, not humans, will dominate commerce; Bitcoin is positioned as the settlement layer for machine-to-machine transactions.

— Specialized AI models beat general-purpose ones; Eli Lilly exemplifies this by building proprietary models on proprietary data, creating a defensible moat that commodity LLMs cannot replicate.

— Peptides (particularly GLP-1s) are the "API key for the human body"—unlocking applications in weight loss, diabetes, addiction, and potentially reversing disease; Eli Lilly's data advantage and acquisition spree position it as the dominant player.

— Healthcare entitlements and household wealth are critical macro factors; companies solving longevity and metabolic disease will reshape the economy and the debt trajectory.

— Treat Bitcoin as a generational wealth transfer tool, not a trading vehicle. Visser allocates 2–3% of portfolio minimum and buys consistently through drawdowns, framing it as a legacy asset (akin to a Patek Philippe watch) rather than a speculative position.

— Rotate exposure toward specialized AI and healthcare/peptide plays (Eli Lilly specifically) as the market narrative shifts from hardware infrastructure to software applications; the next leg of returns will come from companies controlling proprietary data and custom models, not commodity silicon or LLMs.

— Monitor chart technicals (200-day and 200-week moving averages), not narrative hype. Wait for Bitcoin to base and break moving averages on positive supply-demand signals before increasing exposure; avoid FOMO-driven buying in parabolic phases.